Pour accéder à toutes les fonctionnalités de ce site, vous devez activer JavaScript. Voici les instructions pour activer JavaScript dans votre navigateur Web.
L'Institut de recherche interdisciplinaire de Grenoble (Irig) est un institut thématique de la Direction de la Recherche Fondamentale du CEA.
Notre Institut est composé de 5 départements
Les 10 Unités Mixtes de Recherches de l'Irig
Publications, Thèses soutenues, Prix et distinctions
Agenda
Soutenance de thèse
Mardi 12 novembre à 14:30, Salle 205, Accueil principal CEA Grenoble, 17 avenur des Martyrs, Grenoble
Soluble IgM antibodies, the first to respond to antigens, are promising therapeutic targets due to their broad pathogen reactivity, including viruses and tumors, and their potent but complex roles in complement activation and inflammation. IgMs mainly exist as pentamers or hexamers, with superior binding and complement activation compared to IgGs, making them attractive for therapeutic development. However, challenges in production and understanding their function have hindered clinical progress. This study comprehensively characterized recombinant IgM oligomers, focusing on structural and functional differences between constructs with and without the J chain. Structural analysis using cryo-electron microscopy (cryo-EM) and functional assays such as Biolayer Interferometry (BLI), ELISA, liposome-based lysis, and hemolytic tests, revealed that IgM constructs with the J chain formed homogeneous populations, while those without the J chain displayed a mix of pentamers, hexamers, and smaller oligomers. Cryo-EM at 4 Å resolution uncovered that the IgM-Fc hexamer adopts a compact, planar structure with pseudo-hexamer symmetry, distinct from the pentameric form. In the functional assays, surprisingly, constructs without antigen-binding domains demonstrated complement activation. Additionally, carbon nanotube templates were proposed as a novel antigen template for structural studies with IgM, surpassing existing antigen platforms. This work underscores the unique structure and enhanced function of hexameric IgM, highlighting its potential as a therapeutic candidate and paving the way for designing targeted IgM-based treatments for immune diseases.
Haut de page
Acteur majeur de la recherche, du développement et de l'innovation, le CEA intervient dans quatre grands domaines : énergies bas carbone, défense et sécurité, technologies pour l’information et technologies pour la santé.